+ Filter



LASV GPC

Anti-LASV GPC Products
- Recombinant Human Anti-LASV GPC Antibody (clone 18.5C-M30) (VS-0923-XY18)
-
- Species Reactivity: Lassa virus (LASV)
- Type: Human IgG
- Application: ELISA, BLI, Neut
- Human Anti-LASV GPC Vaccinal Antibody (VS-0625-XY57) (VS-0625-XY57)
-
- Species Reactivity: LASV
- Target: LASV GPC
- Host Animal: Human
- Application: ELISA, BLI, Neut
- Type: Human IgG
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
The Old World arenavirus Lassa virus (LASV) is the etiologic agent of the often fatal Lassa hemorrhagic fever (LF). LASV is endemic to West Africa and exhibits a case fatality rate of greater than 50% in hospitalized patients and up to 90% in the third trimester of pregnancy. LASV is an enveloped, negative-stranded RNA virus with an ambisense, bisegmented genome that encodes the following four proteins: the matrix protein (Z), viral polymerase (L), nucleoprotein (NP), and glycoprotein precursor (GPC). GPC is trafficked from the endoplasmic reticulum (ER) through the compartment, where it is heavily N-glycosylated and undergoes processing by the cellular proteases SPase and SKI-1/S1P to produce the mature, prefusion glycoprotein (GP). Each GP monomer consists of the following three noncovalently associated subunits: the stable signal peptide (SSP), the receptor binding subunit (GP1), and the fusion machinery (GP2) (14, 15). Three GP monomers associate on the viral surface to form a trimer that drives viral attachment and cell entry.